Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis

BackgroundWe performed a systematic review and meta-analysis to evaluate the risks of cardiac adverse events in solid tumor patients treated with monotherapy of immune checkpoint inhibitors (ICIs) or combined therapy of ICIs plus chemotherapy.MethodsEligible studies were selected through the followi...

Full description

Bibliographic Details
Main Authors: Jiexuan Hu, Ruyue Tian, Yingjie Ma, Hongchao Zhen, Xiao Ma, Qiang Su, Bangwei Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
cardiovascular toxicity
PD-1/PD-L1 inhibitors
chemotherapy
solid tumors
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.645245/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.645245/full

Similar Items